JP6807921B2 - Ｈｐｖワクチン関連神経免疫異常症候群モデル動物の製造方法 - Google Patents
Ｈｐｖワクチン関連神経免疫異常症候群モデル動物の製造方法 Download PDFInfo
- Publication number
- JP6807921B2 JP6807921B2 JP2018511877A JP2018511877A JP6807921B2 JP 6807921 B2 JP6807921 B2 JP 6807921B2 JP 2018511877 A JP2018511877 A JP 2018511877A JP 2018511877 A JP2018511877 A JP 2018511877A JP 6807921 B2 JP6807921 B2 JP 6807921B2
- Authority
- JP
- Japan
- Prior art keywords
- hpv vaccine
- mice
- vaccine
- ptx
- gardasil
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New breeds of animals
- A01K67/027—New breeds of vertebrates
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Environmental Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Zoology (AREA)
- Animal Husbandry (AREA)
- Biodiversity & Conservation Biology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2016082542 | 2016-04-16 | ||
| JP2016082542 | 2016-04-16 | ||
| PCT/JP2016/082595 WO2017179232A1 (fr) | 2016-04-16 | 2016-11-02 | Procédé de production d'un modèle animal de syndrome neuropathique associé au vaccin contre hpv |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPWO2017179232A1 JPWO2017179232A1 (ja) | 2019-04-18 |
| JP6807921B2 true JP6807921B2 (ja) | 2021-01-06 |
Family
ID=60042593
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018511877A Active JP6807921B2 (ja) | 2016-04-16 | 2016-11-02 | Ｈｐｖワクチン関連神経免疫異常症候群モデル動物の製造方法 |
Country Status (2)
| Country | Link |
|---|---|
| JP (1) | JP6807921B2 (fr) |
| WO (1) | WO2017179232A1 (fr) |
-
2016
- 2016-11-02 JP JP2018511877A patent/JP6807921B2/ja active Active
- 2016-11-02 WO PCT/JP2016/082595 patent/WO2017179232A1/fr active Application Filing
Also Published As
| Publication number | Publication date |
|---|---|
| WO2017179232A1 (fr) | 2017-10-19 |
| JPWO2017179232A1 (ja) | 2019-04-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Jackson | Pathogenesis | |
| US10653759B2 (en) | Methods, antibodies, and vaccines utilizing epitopes of alpha synuclein for treatment of Parkinson's disease | |
| Baek et al. | Bee venom phospholipase A2 ameliorates Alzheimer’s disease pathology in Aβ vaccination treatment without inducing neuro-inflammation in a 3xTg-AD mouse model | |
| WO2002023994A1 (fr) | Methode visant a limiter la croissance des cellules cancereuses a l'aide d'un virus de la rougeole attenue | |
| Ji et al. | Hepatitis B core VLP-based mis-disordered tau vaccine elicits strong immune response and alleviates cognitive deficits and neuropathology progression in Tau. P301S mouse model of Alzheimer’s disease and frontotemporal dementia | |
| Boukhvalova et al. | Herpes simplex virus 1 induces brain inflammation and multifocal demyelination in the cotton rat Sigmodon hispidus | |
| Zurbriggen et al. | Theiler's virus infection in nude mice: viral RNA in vascular endothelial cells | |
| Phillpotts et al. | Monoclonal antibody protects mice against infection and disease when given either before or up to 24 h after airborne challenge with virulent Venezuelan equine encephalitis virus | |
| Lin et al. | The role of the two‐pore domain potassium channel TREK‐1 in the therapeutic effects of escitalopram in a rat model of poststroke depression | |
| Ishii-Katsuno et al. | Reduction of amyloid β-peptide accumulation in Tg2576 transgenic mice by oral vaccination | |
| Kang et al. | Toxoplasma gondii virus‐like particle vaccination alleviates inflammatory response in the brain upon T gondii infection | |
| Rasalingam et al. | Comparative pathogenesis of the SAD-L16 strain of rabies virus and a mutant modifying the dynein light chain binding site of the rabies virus phosphoprotein in young mice | |
| Takeuchi et al. | Nasal vaccine delivery attenuates brain pathology and cognitive impairment in tauopathy model mice | |
| Madar-Balakirski et al. | Preliminary nonclinical safety and immunogenicity of an rVSV-ΔG-SARS-CoV-2-S vaccine in mice, hamsters, rabbits and pigs | |
| Vatzia et al. | Immunization with matrix-, nucleoprotein and neuraminidase protects against H3N2 influenza challenge in pH1N1 pre-exposed pigs | |
| Zuo et al. | Bacille Calmette-Guérin attenuates vascular amyloid pathology and maximizes synaptic preservation in APP/PS1 mice following active amyloid-β immunotherapy | |
| JP6807921B2 (ja) | Ｈｐｖワクチン関連神経免疫異常症候群モデル動物の製造方法 | |
| Zeng et al. | Spatial training promotes short-term survival and neuron-like differentiation of newborn cells in Aβ1-42-injected rats | |
| JP2015518561A5 (fr) | ||
| Sha et al. | In vivo electroporation of a new gene vaccine encoding ten repeats of Aβ3-10 prevents brain Aβ deposition and delays cognitive impairment in young Tg-APPswe/PSEN1dE9 mice | |
| KR102388363B1 (ko) | 알츠하이머병（ａｄ）의 치료 및 예방 | |
| Beaver et al. | Cutaneous vaccination ameliorates Zika virus-induced neuro-ocular pathology via reduction of anti-ganglioside antibodies | |
| Gobbel et al. | Diffuse alterations in synaptic protein expression following focal traumatic brain injury in the immature rat | |
| Joly-Amado et al. | Intraventricular human immunoglobulin distributes extensively but fails to modify amyloid in a mouse model of amyloid deposition | |
| Richardson et al. | Chronic intracerebroventricular infusion of lipopolysaccharide: effects of ibuprofen treatment and behavioural and histopathological correlates |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AA64 | Notification of invalidation of claim of internal priority (with term) |
Free format text: JAPANESE INTERMEDIATE CODE: A241764 Effective date: 20190115 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20190206 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20190712 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20200623 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20200707 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20201201 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20201208 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 6807921 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |